Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Top Cited Papers
- 31 January 2013
- journal article
- review article
- Published by Elsevier BV in Gastroenterology
- Vol. 144 (2), 323-332
- https://doi.org/10.1053/j.gastro.2012.10.005
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitusHepatology, 2012
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA ReductaseCancer Research, 2011
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With DiabetesGastroenterology, 2009
- Hepatitis C infection and risk of diabetes: A systematic review and meta-analysisJournal of Hepatology, 2008
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Statins and cancer preventionNature Reviews Cancer, 2005
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986